Although the exact mechanism underlying the anti-obesity effect of GIP or the GIPR system is unclear, cumulative results support that the therapeutic effect associated with the modulation of the GIP system is mediated by the central nervous system (CNS) [1]. This evidence concerns the gene GIPR and obesity disorder.